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Abstract
The aim of this retrospective analysis was to look at the spectrum of bacterial isolates and their
resistance patterns to the commonly used antIbiotics in the settmg of febrile neutropenia. A total of 127
bacteria were isolated from patients with acute leukemias, lymphoproliferative disorders, aplastic
anaemia and various solid tumours. Fifty-four percent organisms were gram negative; while the rest
were gram positive. E. coli, pseudomónas aeruginosa, staphylococcus aureus, enterococcus and
streptococci were the commonly isolated organisms. Forty-eight percent organisms were isolated from
blood, 16% from urine, 13% from wounds and superficial abscesses and 11% from respiratory tract. E.
coli exhibited a great degree of resistance to the commonly used antibiotics, such as pipericillin (70%),
ofloxacin (50%) and aztreonam (50%). Pseudomonas and kiebsiella also showed varying degree of
resistance against the antibiotics. Staphylococcus aureus and staphylococcus epidennidis were almost
universally resistant to penicillin and showed a variable degree of resistance to other antibiotices too.
Compared to the previous reports, the pattern of bacterial isolates and their resistance to antibiotics has
changed over the past years. Aminolgycosides and third generation cephalosporins seem to be the
choice of antibiotics for the upfront management of febrile neutropenic patients (JPMA 48:364,1998).
Introduction
Chemotherapy results in neutropenia in a great majority of patients. The patients with hematological
and lymphoid malignancies are particularly susceptible 1. Of the total number of patients who develop
neutropenia, about 80% have fever2. A febrile neutropenic patient requires empiric antibiotic therapy,
which should be instituted as early as possible 3. Delay in initiation of treatment may result in
septicaemic shock and is often associated with mortality4. The vast majority of neutropenic febrile
patients (75-80%) do not have a clinical focus of infection at the time of presentation5. Hence, empiric
antibiotic therapy is formulated on the knowledge of common bacterial isolates and their sensitivity
patterns. Gram negative infections were thought to be the most common offending agents and usually a
combinationof aminoglycosides and beta lactam antibiotics result in defervescence1,2. However, in the
past few years, with increasing usage of indwelling catheters and effective treatment of gram negative
infections, there has been a shift in the spectrum of bacterial isolates5,6. Gram positive organisms are
now isolated with increasing frequency and gram negative organisms display more resistance to Blactam and other antibiotics. We report the patterns of isolates as well as their resistance to antibiotics
frnm a single institution in Pakistan.
Patients and Methods
The data was collected retrospectively from all the febrile patients seen under the oncology service
with culture proven bacterial isolates over a period of 15 months. Of the 379 bacterial pathogens
isolated in this period, 127 were identified when the absolute neutrophil count (ANC) of patients was

less than 500/W. The patients either had hematological or non- hematological underlying malignancies
oraplastic anemia, Cultures were obtained from blood, urine, sputum, wound/abscess or any other
identifiable focus of infection. Culture and sensitivity were carried out according to the routine
procedure in the clinical laboratories of our hospital. Briefly, 5 ml of blood was drawn into each of
brain-heart infusion bmth and thioglycollate broth and incubated at 37°C for 24 hours. Gram negative
bacteria were identified using API 20E strips and gram positive bacteria by the catalose test, coagulase
test, sensitivity to optochin and bacitracin discs. Antibiotic sensitivity was performed on diagnostic
sensitivity agar plates by Kirby-Bauer method7.
Results
Over a period of 15 months, 127 bacterial isolates were cultured from a total of 85 patients while they
were neutropenic and febrile. The majority of patients had acute myeloid leukemia (23/85) or various
lymphopmliferative disorders (25/85) including acute lymphoblastic leukemia. Seventeen had aplastic
anaemia and 18/85 bad solid tumors. One patient each had multiple myeloma and agranulocytosis.
Gram negative bacteria accounted for 69/127 (54.5%) of the isolates. E. coli was the single most
common organism isolated, followed by pseudomonas aeruginosa and Klebsiella. Details are shown in
Table 1.

The resistance patterns of the commonly isolated organisms were studied against frequently prescribed
antibiotics. The antibiotics included aminoglycosides, B-lactam antibiotics, monolactams, third
generation cephalosponns and the quinolones.

Table II shows the resistance patterns of E. coli, pseudomonas and Kiebsiella against various
antibiotics. E. coli were resistant to pipencillin in 70% cases and 50% were resistant to ofloxacm,
ameonam and cefixime. Twenty-three peicent of the pseudomonas species were resistant to pipericillin,
whereas 15% were resistant to aztreonam and ofloxacin.
Gram positive organisms comprised 46% (58/127) of the total bacterial isolates. Staphylococcus aureus
was the commonest gram positive organism isolated (15/58), followed by streptococcal species (Table
III).

Staphylococcus epidermidis were isolated on 9 occasions. All but one patient with bacteremia
secondary to staphylococcus epidermidis had an indwelling venous access catheter at the time of the
febrile episode.

Table IV shows the resistance patterns of staphylococcus aureus and epidermidis. Virtually all the
organisms were resistant to penicillin.
Discussion
Grain negative aerobic bacteria have been the predominant- isolated organsism from febrile
neutropenic patients1,3. Over the past few years there has been a shift of microbial flora from grain
neptive to gram positive organisms at many cancer centers5,6. This could be attributed to bettercontrol
of gram negative infections and more frequent use of indwelling venous access devices6. An earlier
study at our institution revealed gram negative organisms to account for 70% of all infections8. The
vast majority were pseudomonas which comprised 31% of all the isolates. As a result, a combination of
amikacin and pipericillin was used commonly to treat prolonged (more than seven days) neutropenic
febrile episodes, whereas ofloxacin was frequently used to treat neutropema expected to last less than
seven days9.
The current study demonstrates that gram positive organisms have increased in frequency at this
institution. Coagulase negative staphylococcus was isolated with increasing frequency, particularly
from patients who had indwelling venous access devices. Gram positive rods of Bacillus species were
likewise isolated from fourpatients. The majority of whom had indwelling catheters. The vast majority
of patients in this series (78%) had either lymphoproliferative ormyelopmliferative disorders or had
aplastic anaemia and as such had prolonged neutropenia. Fungi (candida and aspergillus) were cultured
on 18 occasions from the same patient group during the study period. However, they were excluded
from the overall analysis, since the aim of this study was to investigate the bacterial infections in
neutropenic patients which are important in the early empiric antibiotic management.
The demonstration of nearly 50% of the bacterial isolates to be gram positive organisms is in
agreement with several recent reports. Petrilli et al10 have shown gram positive cocci to account for

52.6% of the infections. Similarly Coullioud et al6 showed 56% of 1147 pathogens to be gram positive
bacteria. However, majority of their patients had indwelling venous lines at the time of febrile episodes.
In our study, 19/28 organisms isolated from patients with indwelling various catheters were gram
positive.
A previous study at this institution showed pseudomonas to be isolated on 31% occasions8, the current
study shows pseudomonas to account for only 11% of the isolates. E. coli were the most frequently
isolated organisms(16%). An important features of this study is the demonstration of increasing
resistance of E. coli to various antibiotics. Of the 20 isolates, 10 were resistant to quinolones, one of the
frequently used drugs for the treatment of such infections11, particularly for those who have low risk
neutropenia12. Pipericillin had been used routinely as an integral part of the neutropenic regimen in the
past. Seventy percent of the E. coli were resistant to this antibiotic as well, while 50% E. coli were also
resistant to aztreonam, a monolactam frequently used as an alternative to the ‘first line’ arnikacin and
pipericillin. E. coli showed 5% and 15% resistance to Aminoglycosides and third generation
cephalosponns respectively. Besides E. coli, resistance to quinolones, beta lactam, monolactams and
third generation cephalosporin has also emerged forpseudomonas and klebsiella.
Another feature of this study is the fact that isolates obtained from any culture-directed site were
included for overall analysis. Many of the studies have used only bacteremic episodes to look at the
pattern of isolated organisms6’7. If bacteremic episodes alone were to be considered, 30/61 i.e., nearly
half the bacteria were gram positive in this study. This is again consistent with the studies mentioned
above. Although the majority of organisms were isolated from blood (48%), followed by urine (16%),
wound/abscesses (13%) or sputum and tracheal aspirate (11%), occasionally micro-organism were also
isolated from sites such as the ascitic fluid, pleural fluid, CSF etc. Hence, it is imperative that every
effort should be made to obtain cultures from all possible sites, particularly as the bacterial spectrum
has changed and new resistance patterns have emerged. Demonstration of antibiotic resistance resulted
in frequent modifications of treatment in these patients.
It is concluded that the gram positive bacteria have increased as a cause of infection in neutropenic
febrile patients, particularly in those with indwelling venous access devices. Multi-drug resistant strains
of gram negative organisms have emerged rapidly. This may pose a great problem in early management
of these patients. A combination of aminoglycosides and third generation cephalosporin seems to be
appropriate for the upfront management at this time. Studies of this nature should be frequently
repeated to document the changing pattern of bacterial isolates and the antibiotic resistance which has
marked implications in the choice of early empiric antibiotic therapy.
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